X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs SUVEN LIFE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS SUVEN LIFE DR. DATSONS LABS/
SUVEN LIFE
 
P/E (TTM) x -10.9 19.4 - View Chart
P/BV x 0.2 3.6 4.5% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 DR. DATSONS LABS   SUVEN LIFE
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
SUVEN LIFE
Mar-16
DR. DATSONS LABS/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs126339 37.1%   
Low Rs31144 21.4%   
Sales per share (Unadj.) Rs133.039.2 338.9%  
Earnings per share (Unadj.) Rs0.27.5 2.0%  
Cash flow per share (Unadj.) Rs6.68.8 75.3%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.849.0 262.9%  
Shares outstanding (eoy) m31.66127.28 24.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.66.2 9.6%   
Avg P/E ratio x516.132.4 1,595.0%  
P/CF ratio (eoy) x11.827.5 43.0%  
Price / Book Value ratio x0.64.9 12.3%  
Dividend payout %026.8 0.0%   
Avg Mkt Cap Rs m2,47730,732 8.1%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m56416 13.4%   
Avg. sales/employee Rs ThNM5,236.1-  
Avg. wages/employee Rs ThNM436.5-  
Avg. net profit/employee Rs ThNM995.5-  
INCOME DATA
Net Sales Rs m4,2114,995 84.3%  
Other income Rs m79194 40.7%   
Total revenues Rs m4,2895,189 82.7%   
Gross profit Rs m5691,233 46.1%  
Depreciation Rs m204167 122.2%   
Interest Rs m43054 793.7%   
Profit before tax Rs m131,205 1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6255 2.4%   
Profit after tax Rs m5950 0.5%  
Gross profit margin %13.524.7 54.7%  
Effective tax rate %48.021.2 226.9%   
Net profit margin %0.119.0 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,8524,986 137.4%   
Current liabilities Rs m6,7111,042 643.9%   
Net working cap to sales %3.379.0 4.2%  
Current ratio x1.04.8 21.3%  
Inventory Days Days16161 263.7%  
Debtors Days Days31839 813.8%  
Net fixed assets Rs m3,6733,126 117.5%   
Share capital Rs m317127 248.7%   
"Free" reserves Rs m3,7613,717 101.2%   
Net worth Rs m4,0786,236 65.4%   
Long term debt Rs m1,671432 386.5%   
Total assets Rs m12,6338,079 156.4%  
Interest coverage x1.023.2 4.4%   
Debt to equity ratio x0.40.1 591.1%  
Sales to assets ratio x0.30.6 53.9%   
Return on assets %3.412.4 27.7%  
Return on equity %0.115.2 0.8%  
Return on capital %7.718.9 40.6%  
Exports to sales %22.987.5 26.2%   
Imports to sales %14.312.2 116.9%   
Exports (fob) Rs m9644,371 22.1%   
Imports (cif) Rs m602611 98.5%   
Fx inflow Rs m9644,666 20.7%   
Fx outflow Rs m607942 64.4%   
Net fx Rs m3573,724 9.6%   
CASH FLOW
From Operations Rs m1,345922 145.9%  
From Investments Rs m-2,256-619 364.2%  
From Financial Activity Rs m-1,200-698 171.8%  
Net Cashflow Rs m-2,111-396 533.4%  

Share Holding

Indian Promoters % 4.5 63.4 7.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 1.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 36.5 257.8%  
Shareholders   20,807 37,287 55.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  MERCK LTD  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; IT Stocks Witness Buying Interest(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the IT sector and FMCG sector witnessing maximum buying interest.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS